Detalhe da pesquisa
1.
SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters.
Nature
; 603(7902): 687-692, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35062015
2.
Breakthrough infections by SARS-CoV-2 variants boost cross-reactive hybrid immune responses in mRNA-vaccinated Golden Syrian hamsters.
PLoS Pathog
; 20(1): e1011805, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38198521
3.
Plitidepsin as an Immunomodulator against Respiratory Viral Infections.
J Immunol
; 212(8): 1307-1318, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38416036
4.
Lipid Nanoparticle Encapsulation Empowers Poly(I:C) to Activate Cytoplasmic RLRs and Thereby Increases Its Adjuvanticity.
Small
; 20(10): e2306892, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37867244
5.
Angiopoietin expression in ovine corpora lutea during the luteal phase: Effects of nutrition, arginine and follicle stimulating hormone.
Gen Comp Endocrinol
; 269: 131-140, 2018 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30195024
6.
Surface-modified measles vaccines encoding oligomeric, prefusion-stabilized SARS-CoV-2 spike glycoproteins boost neutralizing antibody responses to Omicron and historical variants, independent of measles seropositivity.
mBio
; 15(2): e0292823, 2024 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38193729
7.
Enhanced mucosal B- and T-cell responses against SARS-CoV-2 after heterologous intramuscular mRNA prime/intranasal protein boost vaccination with a combination adjuvant.
bioRxiv
; 2024 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38586014
8.
Influenza breakthrough infection in vaccinated mice is characterized by non-pathological lung eosinophilia.
Front Immunol
; 14: 1217181, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37600776
9.
Host immune responses associated with SARS-CoV-2 Omicron infection result in protection or pathology during reinfection depending on mouse genetic background.
Res Sq
; 2023 Nov 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38077015
10.
Multicomponent intranasal adjuvant for mucosal and durable systemic SARS-CoV-2 immunity in young and aged mice.
NPJ Vaccines
; 8(1): 96, 2023 Jun 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37386041
11.
Breakthrough infections by SARS-CoV-2 variants boost cross-reactive hybrid immune responses in mRNA-vaccinated Golden Syrian Hamsters.
bioRxiv
; 2023 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37425792
12.
Surface-modified measles vaccines encoding oligomeric, fusion-stabilized SARS-CoV-2 spike glycoproteins bypass measles seropositivity, boosting neutralizing antibody responses to omicron and historical variants.
bioRxiv
; 2022 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36561187
13.
Discovery and intranasal administration of a SARS-CoV-2 broadly acting neutralizing antibody with activity against multiple Omicron subvariants.
Med
; 3(10): 705-721.e11, 2022 10 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36044897